Elzasonan hydrochloride

Drug Profile

Elzasonan hydrochloride

Alternative Names: CP 448187; CP 448187-01; Elzasonan

Latest Information Update: 13 Aug 2013

Price : $50

At a glance

  • Originator Pfizer
  • Class Antidepressants; Small molecules
  • Mechanism of Action Serotonin 1B receptor antagonists; Serotonin 1D receptor antagonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • Discontinued Major depressive disorder; Obsessive-compulsive disorders

Most Recent Events

  • 13 Aug 2013 Discontinued - Phase-II for Obsessive-compulsive disorders in USA (unspecified route)
  • 31 Dec 2005 No development reported - Phase-II for Obsessive-compulsive disorders in USA (unspecified route)
  • 28 Nov 2002 Phase-II clinical trials in Obsessive-compulsive disorders in USA (unspecified route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top